Sanofi announces positive data for frexalimab product to treat multiple sclerosis

PARIS (Reuters) – French healthcare company Sanofi announced on Wednesday positive data for its frexalimab product aimed at treating multiple sclerosis, and that the firm plans to initiate pivotal trials in multiple sclerosis in early 2024.

(Reporting by Sudip Kar-Gupta; Editing by Shri Navaratnam)

Rivermen fall in Game 3 of President's Cup Finals

3h ago

China asks banks to pause new loans to US-sanctioned refiners, Bloomberg News reports

3h ago

EU countries, lawmakers clinch provisional deal on watered-down AI rules

3h ago

Trump sees swift end to war as Iran reviews US peace proposal

2h ago

MLB roundup: Andy Pages belts 3 homers as Dodgers down Astros

14m ago

Stocks perched on record peak, dollar defensive on peace hopes

4h ago

Classic Hits

12:00 AM - 5:30 AM

Now Playing

93.3 The Drive

Loading Songs

No feed items available at this time.

Pause Auto-Update | Back to Top

No feed items available at this time.

Pause Auto-Update | Back to Top

Sanofi announces positive data for frexalimab product to treat multiple sclerosis

Current Weather »

Peoria, IL

The Drive on FB

The Drive on Instagram